Skip to main content
. 2012 Feb 21;20(5):1056–1062. doi: 10.1038/mt.2012.27

Figure 3.

Figure 3

Short-term effects of anti-CD20 therapy-induced changes in peripheral blood mononuclear cells. Percentages of CD19+ B lymphocytes, CD3+CD4+, and CD3+CD8+ T cells, CD16+CD56+ NK cells and CD4+CD25+CD127 regulatory T cells. (a) Patients without disease recurrence (patients #1, open circle; #2, closed circle; #3, open square; #4, closed triangle; #5, closed square). (b) Patients with disease recurrence (patients #7, closed triangle; #8, open square; #9, open circle).